OBJECTIVES: To measure cerebrospinal fluid (CSF) tau in HIV infected patients with acute neurological episodes and to correlate the findings with the type and severity of neurological disease. METHODS: CSF tau was prospectively measured in 76 consecutive HIV infected patients admitted to a specialist unit at UCL Hospitals, London, for investigation of acute neurological episodes: the results were compared with the clinical diagnoses. RESULTS: 24 patients had HIV associated dementia complex (HADC), 10 had lymphoma (including four with primary CNS lymphoma), 20 had cerebral infections (including five with CMV encephalitis, five with VZV infection, seven with cryptococcal meningitis, two with toxoplasmosis, and one with progressive multifocal leucoencephalopathy); 22 patients had miscellaneous conditions, including nine with self limiting headache/fever. 62 patients (82%) had normal CSF tau concentration and 14 patients (18%) had elevated tau. In those with HADC, there was no correlation between the degree of dementia or atrophy on magnetic resonance imaging and CSF tau. Elevated CSF tau was associated with poor outcome as six of eight patients who died within 4 weeks of lumbar puncture had elevated tau (p = 0.0024, two tailed Fisher's exact test). CONCLUSIONS: CSF tau levels are not elevated in the majority of HIV infected patients presenting with acute neurological episodes. CSF tau levels show no correlation with severity of dementia/atrophy on magnetic resonance imaging. Although elevated CSF tau was observed in some patients with conditions causing cerebral necrosis, the finding did not delineate underlying pathology but was associated with poor outcome.
OBJECTIVES: To measure cerebrospinal fluid (CSF) tau in HIV infectedpatients with acute neurological episodes and to correlate the findings with the type and severity of neurological disease. METHODS: CSF tau was prospectively measured in 76 consecutive HIV infectedpatients admitted to a specialist unit at UCL Hospitals, London, for investigation of acute neurological episodes: the results were compared with the clinical diagnoses. RESULTS: 24 patients had HIV associated dementia complex (HADC), 10 had lymphoma (including four with primary CNS lymphoma), 20 had cerebral infections (including five with CMV encephalitis, five with VZV infection, seven with cryptococcal meningitis, two with toxoplasmosis, and one with progressive multifocal leucoencephalopathy); 22 patients had miscellaneous conditions, including nine with self limiting headache/fever. 62 patients (82%) had normal CSF tau concentration and 14 patients (18%) had elevated tau. In those with HADC, there was no correlation between the degree of dementia or atrophy on magnetic resonance imaging and CSF tau. Elevated CSF tau was associated with poor outcome as six of eight patients who died within 4 weeks of lumbar puncture had elevated tau (p = 0.0024, two tailed Fisher's exact test). CONCLUSIONS: CSF tau levels are not elevated in the majority of HIV infectedpatients presenting with acute neurological episodes. CSF tau levels show no correlation with severity of dementia/atrophy on magnetic resonance imaging. Although elevated CSF tau was observed in some patients with conditions causing cerebral necrosis, the finding did not delineate underlying pathology but was associated with poor outcome.
Authors: B Giometto; S F An; M Groves; T Scaravilli; J F Geddes; R Miller; B Tavolato; A A Beckett; F Scaravilli Journal: Ann Neurol Date: 1997-07 Impact factor: 10.422
Authors: M Otto; J Wiltfang; H Tumani; I Zerr; M Lantsch; J Kornhuber; T Weber; H A Kretzschmar; S Poser Journal: Neurosci Lett Date: 1997-04-11 Impact factor: 3.046
Authors: H Arai; Y Morikawa; M Higuchi; T Matsui; C M Clark; M Miura; N Machida; V M Lee; J Q Trojanowski; H Sasaki Journal: Biochem Biophys Res Commun Date: 1997-07-18 Impact factor: 3.575
Authors: R F Miller; S B Lucas; M A Hall-Craggs; N S Brink; F Scaravilli; R J Chinn; B E Kendall; I G Williams; M J Harrison Journal: J Neurol Neurosurg Psychiatry Date: 1997-04 Impact factor: 10.154
Authors: M J Harrison; S P Newman; M A Hall-Craggs; C J Fowler; R Miller; B E Kendall; M Paley; I Wilkinson; B Sweeney; S Lunn; S Carter; I Williams Journal: J Neurol Neurosurg Psychiatry Date: 1998-09 Impact factor: 10.154
Authors: R J Ellis; P Seubert; R Motter; D Galasko; R Deutsch; R K Heaton; M P Heyes; J A McCutchan; J H Atkinson; I Grant Journal: Neurosci Lett Date: 1998-09-18 Impact factor: 3.046
Authors: Magnus Gisslén; Jan Krut; Ulf Andreasson; Kaj Blennow; Paola Cinque; Bruce J Brew; Serena Spudich; Lars Hagberg; Lars Rosengren; Richard W Price; Henrik Zetterberg Journal: BMC Neurol Date: 2009-12-22 Impact factor: 2.474
Authors: Albert M Anderson; David Croteau; Ronald J Ellis; Debra Rosario; Michael Potter; Gilles J Guillemin; Bruce J Brew; Steven Paul Woods; Scott L Letendre Journal: J Neuroimmunol Date: 2018-03-18 Impact factor: 3.478
Authors: Virawudh Soontornniyomkij; David J Moore; Ben Gouaux; Benchawanna Soontornniyomkij; Erick T Tatro; Anya Umlauf; Eliezer Masliah; Andrew J Levine; Elyse J Singer; Harry V Vinters; Benjamin B Gelman; Susan Morgello; Mariana Cherner; Igor Grant; Cristian L Achim Journal: AIDS Date: 2012-11-28 Impact factor: 4.177
Authors: Sérgio Monteiro de Almeida; Clea E Ribeiro; Indianara Rotta; Mauro Piovesan; Bin Tang; Florin Vaida; Sonia Mara Raboni; Scott Letendre; Michael Potter; Meire S Batistela Fernandes; Ronald J Ellis Journal: J Neurovirol Date: 2017-10-23 Impact factor: 2.643
Authors: Steven Paul Woods; Erin E Morgan; Jennifer Marquie-Beck; Catherine L Carey; Igor Grant; Scott L Letendre Journal: Cogn Behav Neurol Date: 2006-12 Impact factor: 1.600
Authors: Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah Journal: Curr HIV Res Date: 2015 Impact factor: 1.581